Offering the nasal flu vaccine in daycare for young children
Official title: Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
Run by Turku University Hospital · NCT07310472 · Data updated 2026-11-12
This project will test whether offering the nasal (spray) influenza vaccine at daycare gets more children vaccinated than offering the vaccine only at healthcare clinics.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years to 6 Years |
| Sex | All |
| Enrollment | 6000 (estimated) |
| Sponsor | Turku University Hospital Government |
| Locations | 1 site (Turku) |
| Status | Recruiting |
| Started | October 27, 2025 |
| Main results expected | March 31, 2026 |
| Study ends | March 31, 2026 |
| Registry record updated | January 22, 2026 |
| Trial ID | NCT07310472 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are young children who attend early childhood education/daycare in Turku.
✕Probably not a fit
Children who do not attend daycare, who live outside Turku, or who cannot receive the live attenuated nasal vaccine for medical reasons may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare children attending early childhood education in Turku who are offered the live attenuated nasal influenza vaccine at their daycare (with the option to get it at healthcare) to a comparison group offered vaccination only at healthcare clinics. The primary outcome is the proportion of children who receive influenza vaccination in each group during the campaign. The intervention leverages existing daycare settings to reduce barriers and measure whether on-site availability increases uptake. The trial includes all children attending daycare in Turku with no additional exclusion criteria provided.
Why it matters
Potential benefit: If successful, offering the nasal vaccine in daycare could raise vaccination rates and reduce influenza-related illness among young children.
How similar studies have gone: Previous vaccination programs delivered in schools and childcare settings have often increased uptake, so this approach has precedent and supportive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Attending early childhood education (daycare) in the city of Turku Exclusion Criteria: * No exclusion criteria
Where it's running
-
University of Turku
Turku, Finland Recruiting
Study contacts
- Study coordinator: Ville Peltola, MD, PhD
- Email: ville.peltola@varha.fi
- Phone: +35823132415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Influenza Vaccine Immunogenicity in Older Adults with Repeated Vaccination
This study tests how different flu vaccines perform in adults 65+ who get yearly vaccines to see if age and repeated vaccination affect the immune response.
-
Evaluating the impact of influenza vaccination and certain medications on COVID-19 outcomes
This study is trying to see if getting the flu vaccine or taking certain medications helps people in the hospital recover better from COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.